Correction: Triglyceride-glucose index and subclinical left ventricular dysfunction across cardiovascular-kidney-metabolic syndrome stages: a 7-year retrospective cohort study - Summary - MDSpire

Correction: Triglyceride-glucose index and subclinical left ventricular dysfunction across cardiovascular-kidney-metabolic syndrome stages: a 7-year retrospective cohort study

  • By

  • Kun-Zhe Tsai

  • Gen-Min Lin

  • Chunho Yun

  • Kuotzu Sung

  • Charles Jia-Yin Hou

  • Hung-I Yeh

  • Nguyen Ngoc Khoi Truong

  • Chung-Lieh Hung

  • July 13, 2026

Share

Objective:

To correct the ethics approval number for the study on triglyceride-glucose index and subclinical left ventricular dysfunction.

Key Findings:
  • The ethics approval number was corrected from 'No. 17MMHIS082e' to 'Nos. 14MMHIS172, and 18MMHIS180e'.
Interpretation:

The original article has been updated to reflect the correct ethics approval numbers.

Conclusion:

Sources:

Original Source(s)

Correction: Triglyceride-glucose index and subclinical left ventricular dysfunction across cardiovascular-kidney-metabolic syndrome stages: a 7-year retrospective cohort study

  • by Kun-Zhe Tsai, Gen-Min Lin, Chunho Yun, Kuotzu Sung, Charles Jia-Yin Hou, Hung-I Yeh, Nguyen Ngoc Khoi Truong, Chung-Lieh Hung

  • July 13, 2026

Related Content

Cumulative triglyceride-glucose-body mass index exposure and cardiovascular disease risk: findings from the Kailuan study

Echocardiographic assessment of left ventricular longitudinal function in critically ill patients

AI Model Improves Interpretation of Cardiac Magnetic Resonance Imaging Scans